The International Conference on Harmonization (ICH) is involved in promoting public health, improve efficiency of new drug development and registration process among other objectives. In order to accomplish this, ICH has developed and implemented harmonized guidelines and standards, also known as ICH6.
Over 50 guidelines on technical requirements on:
Quality, Safety and Efficacy
• Efficacy – 14 topics/17 guidelines
• Safety – 8 topics/16 guidelines
• Quality – 9 topics/23 guidelines
- Maintenance of ICH Controlled Terminology Lists
- Medical dictionary for adverse event reporting and coding
of clinical trial data (MedDRA)
- Electronic Standards for the Transfer of Regulatory
- Common Technical Document (CTD & eCTD)
The European Medicines Agency (EMA) is a decentralised body of the EU. EMA is responsible for centralised procedure and co-ordination of EU network + plays a role in stimulating innovation and research in the pharmaceutical sector.
EMA is not an FDA for Europe
EMA responsibility does not include:
- Evaluation of all medicines in the EU
- Research/development of medicines
- Clinical trial approval
- Medical devices
- EU healthcare policies
Conclusion: ICH-GCP guidelines brought forth public awareness that there was a need to control and regulate clinical trials dealing with drugs and human subjects.
ICH main goal is to provide a unified standard for the European Union (EU), Japan and the United States to facilitate the mutual acceptance of clinical data by the regulatory authorities in these jurisdictions.
Presentation – ICH and EU regulatory – www.ema.europa.eu
Fair Use Notice: Images/logos/graphics on this page contains some copyrighted material whose use has not been authorized by the copyright owners. We believe that this not-for-profit, educational, and/or criticism or commentary use on the Web constitutes a fair use of the copyrighted material (as provided for in section 107 of the US Copyright Law).